Physician Spotlight

Sridharan Gururangan, MRCP (UK) Lilian S. Wells Department of Neurosurgery University of Florida, Gainesville, FL Read More
Cohen, M.D.

Kenneth Cohen, M.D.

Director of Pediatric Neuro-Oncology and Clinical Director of Division of Pediatric Oncology

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Dr. Cohen is Professor of Oncology and Pediatrics, Director of Pediatric Neuro-Oncology and Clinical Director of the Division of Pediatric Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

He received his undergraduate degree at Brown University and earned his MD at the Upstate Medical University, in Syracuse, NY. He did his general Pediatric Residency and Chief Residency at the University of Colorado, and completed his Pediatric Hematology/Oncology Fellowship at Johns Hopkins. He has served on the faculty of Johns Hopkins since 1994. 

Dr. Cohen is co-chair of the High-Grade Glioma Committee for the Children’s Oncology Group. He is the lead author for the PDQ® Cancer Information — National Cancer Institute brain tumor treatment summaries. He was recently appointed to the Scientific Advisory Committee for the St. Baldrick’s Foundation. He also serves on the scientific advisory boards of the Childhood Brain Tumor Foundation and Curing Kids Cancer. He is also the Chair of the Johns Hopkins Institutional Review Board #6.

The Pediatric Neuro-Oncology program at Hopkins, which he heads, conducts a broad range of research centered primarily around the development and testing of new therapies for children with brain tumors. Recent research has focused on the most high-risk brain tumors, including the use of molecularly targeted therapies and novel delivery systems. The multidisciplinary nature of this work translates into continual collaboration with specialists in pediatric neurosurgery, radiation oncology, neuropathology, neuroradiology, neurology, neuro-ophthalmology, and neuropsychology.

As Clinical Director of the Pediatric Oncology Division, Dr. Cohen is responsible for the operation of all of the division’s inpatient and outpatient services. In addition, he oversees the full range of clinical trials under way throughout the division.